These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38548090)

  • 21. Nicotine affects bone resorption and suppresses the expression of cathepsin K, MMP-9 and vacuolar-type H(+)-ATPase d2 and actin organization in osteoclasts.
    Tanaka H; Tanabe N; Kawato T; Nakai K; Kariya T; Matsumoto S; Zhao N; Motohashi M; Maeno M
    PLoS One; 2013; 8(3):e59402. PubMed ID: 23555029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases.
    Hao L; Chen J; Zhu Z; Reddy MS; Mountz JD; Chen W; Li YP
    J Periodontol; 2015 Aug; 86(8):972-83. PubMed ID: 25879791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibitory effect of 8-prenylnaringenin on osteoclastogensis of bone marrow cells and bone resorption activity].
    Lü X; Zhou Y; Chen KM; Zhao Z; Zhou J; Ma XN
    Yao Xue Xue Bao; 2013 Mar; 48(3):347-51. PubMed ID: 23724646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity analysis of cathepsin K/chondroitin 4-sulfate interactions.
    Cherney MM; Lecaille F; Kienitz M; Nallaseth FS; Li Z; James MN; Brömme D
    J Biol Chem; 2011 Mar; 286(11):8988-98. PubMed ID: 21193413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
    Zenger S; Hollberg K; Ljusberg J; Norgård M; Ek-Rylander B; Kiviranta R; Andersson G
    Bone; 2007 Nov; 41(5):820-32. PubMed ID: 17765026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Ectosteric Inhibitor of Cathepsin K Inhibits Bone Resorption in Ovariectomized Mice.
    Panwar P; Xue L; Søe K; Srivastava K; Law S; Delaisse JM; Brömme D
    J Bone Miner Res; 2017 Dec; 32(12):2415-2430. PubMed ID: 28745432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice.
    Starczak Y; Reinke DC; Barratt KR; Russell PK; Clarke MV; Davey RA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105857. PubMed ID: 33647520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways.
    van Heerden B; Kasonga A; Kruger MC; Coetzee M
    Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the discovery of cathepsin K inhibitors on bone resorption.
    Lu J; Wang M; Wang Z; Fu Z; Lu A; Zhang G
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):890-904. PubMed ID: 29723068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solution structure of CXCL13 and heparan sulfate binding show that GAG binding site and cellular signalling rely on distinct domains.
    Monneau YR; Luo L; Sankaranarayanan NV; Nagarajan B; Vivès RR; Baleux F; Desai UR; Arenzana-Seidedos F; Lortat-Jacob H
    Open Biol; 2017 Oct; 7(10):. PubMed ID: 29070611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.
    Lark MW; Stroup GB; James IE; Dodds RA; Hwang SM; Blake SM; Lechowska BA; Hoffman SJ; Smith BR; Kapadia R; Liang X; Erhard K; Ru Y; Dong X; Marquis RW; Veber D; Gowen M
    Bone; 2002 May; 30(5):746-53. PubMed ID: 11996914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of Ac45 Simultaneously Inhibits Osteoclast-Mediated Bone Resorption and Attenuates Dendritic Cell-Mediated Inflammation through Impairing Acidification and Cathepsin K Secretion.
    Yang W; Zhu Z; Li L; McVicar A; Gao N; Wang L; Li YP; Chen W
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel role for cathepsin K in periosteal osteoclast precursors during fracture repair.
    Walia B; Lingenheld E; Duong L; Sanjay A; Drissi H
    Ann N Y Acad Sci; 2018 Mar; 1415(1):57-68. PubMed ID: 29479711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Mild Inhibition of Cathepsin K Paradoxically Stimulates the Resorptive Activity of Osteoclasts in Culture.
    Pirapaharan DC; Søe K; Panwar P; Madsen JS; Bergmann ML; Overgaard M; Brömme D; Delaisse JM
    Calcif Tissue Int; 2019 Jan; 104(1):92-101. PubMed ID: 30194476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and engineering of S100A12-heparan sulfate interactions.
    Zhang X; Ong C; Su G; Liu J; Xu D
    Glycobiology; 2020 Jul; 30(7):463-473. PubMed ID: 31942981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate.
    Li Z; Hou WS; Escalante-Torres CR; Gelb BD; Bromme D
    J Biol Chem; 2002 Aug; 277(32):28669-76. PubMed ID: 12039963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory Effects of Cathepsin K Inhibitor (ODN-MK-0822) on the Paracrine Pro-Osteoclast Factors of Breast Cancer Cells.
    Vashum Y; Kottaiswamy A; Bupesh G; Singh RP; Kalaiselvan P; Thiagarajan K; Samuel S
    Curr Mol Pharmacol; 2021; 14(6):1134-1145. PubMed ID: 33573566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
    Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
    J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
    Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cathepsin K inhibitors: a novel target but promising approach in the treatment of osteoporosis.
    Helali AM; Iti FM; Mohamed IN
    Curr Drug Targets; 2013 Dec; 14(13):1591-600. PubMed ID: 23957815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.